These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 23681221

  • 21. Favorable response to composite treatment including infliximab in a case of granulomatous cheilitis with Crohn's disease.
    Koga M, Koga K, Tatsukawa R, Imafuku S.
    J Dermatol; 2015 Jun; 42(6):651-2. PubMed ID: 25809090
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Development of diffuse alopecia with psoriasis-like eruptions during administration of infliximab for Crohn's disease.
    Kawashima K, Ishihara S, Yamamoto A, Ohno Y, Fukuda K, Onishi K, Kinoshita Y.
    Inflamm Bowel Dis; 2013 Mar; 19(3):E33-4. PubMed ID: 22508420
    [No Abstract] [Full Text] [Related]

  • 26. [Renal amyloidosis in a female with familial Mediterranean fever: clinical response to treatment with colchicine and infliximab].
    Heras M, Sánchez R, Saiz A, Fernández-Reyes MJ, Molina A, Alvarez-Ude F.
    Nefrologia; 2009 Mar; 29(4):373-5. PubMed ID: 19668321
    [No Abstract] [Full Text] [Related]

  • 27. Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab.
    Rebelo A, Leite S, Cotter J.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():37-9. PubMed ID: 21175236
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Development of metastatic Crohn's disease of the skin while on anti-TNF biologics.
    Patel AV, Jones DM, Hill JC, MacDermott RP.
    Inflamm Bowel Dis; 2012 Jun 14; 18(6):1188-90. PubMed ID: 22294342
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab.
    Korzenik JR.
    Gastroenterol Clin North Am; 2004 Jun 14; 33(2):285-301, ix. PubMed ID: 15177539
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.